NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
NRXS Neuraxis
- 2.160
- -0.120-5.26%
Close Feb 25 16:00 ET
15.50MMarket Cap-1.79P/E (TTM)
2.281High2.160Low16.61KVolume2.280Open2.280Pre Close37.29KTurnover0.50%Turnover RatioLossP/E (Static)7.18MShares3.78052wk High-8.64P/B7.17MFloat Cap2.05052wk Low--Dividend TTM3.32MShs Float6.930Historical High--Div YieldTTM5.30%Amplitude1.800Historical Low2.245Avg Price1Lot Size
About Neuraxis Company
NeurAxis, Inc. develops neuromodulation therapies to address chronic and debilitating conditions in children. Its product IB-Stim is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
Company Profile
SymbolNRXS
Company NameNeuraxis
Listing DateAug 9, 2023
Issue Price6.00
Founded2011
CEOMr. Brian Carrico
MarketAMEX
Employees19
Fiscal Year Ends12-31
Address11611 North Meridian Street,Suite 330
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-812-689-0791
Websitehttp://neuraxis.com
Company Executives
- Name
- Position
- Salary
- Brian Carrico
- President, Chief Executive Officer and Director
- 839.40K
- Dr. Thomas Carrico
- Chief Regulatory Officer, Compliance Officer and Privacy Officer
- 411.10K
- Dr. Adrian Miranda
- Chief Medical Officer, Senior Vice President, Science and Technology
- 323.05K
- Timothy Henrichs
- Chief Financial Officer
- 43.70K
- Beth Keyser
- Independent Director
- 43.70K
- Bradley Mitch Watkins
- Independent Director
- 43.70K
- Kristin A. Ferge
- Independent Director
- --
- Christopher Robin Brown
- Independent Director
- --